Plasma cell-free DNA methylation marks for episodic memory impairment: a pilot twin study

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Episodic memory decline is an early Alzheimer's disease (AD) symptom.
• Current AD diagnosis occurs late, after irreversible neurodegeneration.
• Early AD biomarkers are crucial for timely intervention.

Purpose of the Study:

• To identify early Alzheimer's disease biomarkers.
• To analyze plasma cell-free DNA methylation profiles for associations with episodic memory performance.

Main Methods:

• Genome-wide bisulphite sequencing of plasma cell-free DNA (cfDNA).
• Comparison of cfDNA methylation profiles in Finnish twin pairs with varying episodic memory performance.
• Analysis of cfDNA fragment amounts and genomic coverage.

Main Results:

• No significant associations were found between plasma cfDNA methylation profiles and episodic memory performance.
• Substantial individual variation in cfDNA fragment amounts and genomic coverage was observed.
• The chosen method demonstrated limitations for large-scale comparative studies due to cfDNA variability.

Conclusions:

• Plasma cfDNA methylation analysis using genome-wide bisulphite sequencing is not currently an optimal method for identifying early Alzheimer's disease markers in large populations.
• The variability in cfDNA characteristics hinders robust group comparisons.
• Further research into cfDNA analysis methods or alternative biomarkers is warranted for early AD detection.